ArticleEBioMedicine2026
Cataract GWAS meta-analysis and multi-omics Mendelian randomisation inform disease mechanisms and candidate target prioritisation.
Article in EBioMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCataract is a highly prevalent cause of visual impairment and blindness worldwide. Although genome-wide association studies (GWAS) have mapped multiple cataract risk loci, further work is required towards translating these signals and integrating multi-omics evidence for preventing or delaying age-related cataract progression.
methodsA senile cataract GWAS was first conducted in All of Us, followed by ancestry-specific GWAS meta-analyses in European-ancestry (161,812 cases and 1,099,738 controls) and East Asian ancestry (66,679 cases and 521,995 controls). To prioritise candidate targets, we performed Mendelian randomisation (MR) and colocalisation using cis-expression quantitative trait loci (cis-eQTL) instruments from eQTLGen. We then conducted a plasma proteome-wide cis-pQTL MR scan with colocalisation using UKB-PPP and deCODE for European analyses, and cis-pQTL data from the China Kadoorie Biobank for East Asian analyses.
findingsWe identified 78 and 4 independent loci for cataract in Europeans and East Asians, respectively, including 8 and 3 putatively unreported loci. By integrating the meta-GWAS with cis-eQTL MR, we prioritised 16 genes, including MTMR3, NT5DC2, and EFNA1, with eQTL-GWAS colocalisation further supporting MTMR3 and NT5DC2. Proteome-wide cis-pQTL MR prioritised 32 proteins for senile cataract in Europeans, and colocalisation refined these to EFNA1 and RALY. In East Asians, MR highlighted APOE and ALDH2 as candidate targets. We also identified colocalised pleiotropic signals shared between cataract and related traits, including myopia, hypertension, and type 2 diabetes, highlighting candidate genes such as TCF7L2, BMP4, CDKAL1, PAX4, and ALDH2.
interpretationThese findings advance cross-ancestry understanding of cataract genetic architecture and prioritise genetically supported candidates.
fundingThis work was supported by the Joint Funds for the Innovation of Science and Technology, Fujian Joint Innovation Fund in Science and Technology Project (Grant No. 2025Y9437).
Indexed as
Identifiers
42771993What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.